IMDRX
Price
$12.97
Change
+$0.08 (+0.62%)
Updated
Oct 20 closing price
Net Assets
1.12B
RLBCX
Price
$39.01
Change
+$0.26 (+0.67%)
Updated
Oct 20 closing price
Net Assets
265.62B
Interact to see
Advertisement

IMDRX vs RLBCX

Header iconIMDRX vs RLBCX Comparison
Open Charts IMDRX vs RLBCXBanner chart's image
Transamerica Asset Allocation Mod R
Price$12.97
Change+$0.08 (+0.62%)
VolumeN/A
Net Assets1.12B
American Funds American Balanced R3
Price$39.01
Change+$0.26 (+0.67%)
VolumeN/A
Net Assets265.62B
IMDRX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
IMDRX vs. RLBCX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMDRX is a Hold and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 266B vs. IMDRX (1.12B). IMDRX pays higher dividends than RLBCX: IMDRX (1.80) vs RLBCX (1.49). IMDRX was incepted earlier than RLBCX: IMDRX (19 years) vs RLBCX (23 years). IMDRX (1.33) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. IMDRX (17.00). IMDRX has a lower initial minimum investment than RLBCX: IMDRX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 9.01 vs. IMDRX (7.68). RLBCX return over 5 years is better than : 42.54 vs. IMDRX (18.52).
IMDRXRLBCXIMDRX / RLBCX
Total Expense Ratio1.330.89149%
Annual Report Gross Expense Ratio1.330.89149%
Fund Existence19 years23 years-
Gain YTD12.47815.13282%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.12B266B0%
Annual Yield % from dividends1.801.49121%
Returns for 1 year7.689.0185%
Returns for 3 years38.2949.6677%
Returns for 5 years18.5242.5444%
Returns for 10 years19.5370.2828%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP1.470.07
+5.00%
PMV Pharmaceuticals
OWL16.680.50
+3.09%
Blue Owl Capital
AROW26.820.68
+2.60%
Arrow Financial Corp
LFST5.160.12
+2.38%
LifeStance Health Group
JFBR3.740.05
+1.36%
Jeffs Brands Ltd